"Designing Growth Strategies is in our DNA"

Psoriasis Treatment Market Size, Share & Industry Analysis, By Drug Class (TNF Inhibitors, Interleukin Inhibitors [IL-17, IL-23/p19, and IL-12/23 p40 Inhibitors], PDE4 Inhibitors, JAK Inhibitors, and Corticosteroids), By Indication (Plaque Psoriasis, Psoriatic Arthritis, Guttate Psoriasis, and Inverse Psoriasis), By Product Type (Biologics and Non-Biologics), By Route of Administration (Oral, Parenteral/Systemic, and Topical), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Specialty Pharmacies), and Regional Forecast, 2026-2034

Last Updated: September 14, 2026 | Format: PDF | Report ID: FBI100600

 

Buy Now

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities 
    4. Market Trends
    5. Market Challenges
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Key Industry Developments, By Key Players
    3. Pipeline Analysis, By Key Players
    4. Overview: Regulatory Scenario & Reimbursement Scenario, By Key Countries/Region
    5. Prevalence of Psoriasis, By Key Countries, 2025
  5. Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1.  TNF Inhibitors
      2. Interleukins Inhibitors
        1. IL-17 Inhibitors
        2. IL-23/p19 Inhibitors
        3. IL-12/23 p40 Inhibitors
        4. Other Interleukins
      3. PDE4 Inhibitors
      4. TYK2 Inhibitors
      5. JAK Inhibitors
      6. Corticosteroids
      7. Vitamin D Analogs
      8. Retinoids
      9. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1.  Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Guttate Psoriasis
      4. Inverse Psoriasis
      5. Pustular Psoriasis
      6. Erythrodermic Psoriasis
      7. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1.  Biologics
      2.  Non-Biologics
    4.  Market Analysis, Insights and Forecast – By Route of Administration
      1.  Oral
      2.  Parenteral/Systemic
      3.  Topical
    5. Market Analysis, Insights and Forecast – By Age Group
      1.  Pediatric
      2.  Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1.  Hospital Pharmacies
      2. Retail Pharmacies
      3. Specialty Pharmacies
      4. Online Pharmacies
    7. Market Analysis, Insights and Forecast – By Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1.  TNF Inhibitors
      2. Interleukins Inhibitors
        1. IL-17 Inhibitors
        2. IL-23/p19 Inhibitors
        3. IL-12/23 p40 Inhibitors
        4. Other Interleukins
      3. PDE4 Inhibitors
      4. TYK2 Inhibitors
      5. JAK Inhibitors
      6. Corticosteroids
      7. Vitamin D Analogs
      8. Retinoids
      9. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1.  Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Guttate Psoriasis
      4. Inverse Psoriasis
      5. Pustular Psoriasis
      6. Erythrodermic Psoriasis
      7. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1.  Biologics
      2.  Non-Biologics
    4.  Market Analysis, Insights and Forecast – By Route of Administration
      1.  Oral
      2.  Parenteral/Systemic
      3.  Topical
    5. Market Analysis, Insights and Forecast – By Age Group
      1.  Pediatric
      2.  Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1.  Hospital Pharmacies
      2. Retail Pharmacies
      3. Specialty Pharmacies
      4. Online Pharmacies
    7. Market Analysis, Insights and Forecast  – By Country
      1.  U.S. 
        1.  By Indication
      2.  Canada 
        1.  By Indication
  7. Europe Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1.  TNF Inhibitors
      2. Interleukins Inhibitors
        1. IL-17 Inhibitors
        2. IL-23/p19 Inhibitors
        3. IL-12/23 p40 Inhibitors
        4. Other Interleukins
      3. PDE4 Inhibitors
      4. TYK2 Inhibitors
      5. JAK Inhibitors
      6. Corticosteroids
      7. Vitamin D Analogs
      8. Retinoids
      9. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1.  Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Guttate Psoriasis
      4. Inverse Psoriasis
      5. Pustular Psoriasis
      6. Erythrodermic Psoriasis
      7. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1.  Biologics
      2.  Non-Biologics
    4.  Market Analysis, Insights and Forecast – By Route of Administration
      1.  Oral
      2.  Parenteral/Systemic
      3.  Topical
    5. Market Analysis, Insights and Forecast – By Age Group
      1.  Pediatric
      2.  Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1.  Hospital Pharmacies
      2. Retail Pharmacies
      3. Specialty Pharmacies
      4. Online Pharmacies
    7. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1.  U.K 
        1. By Indication
      2.  Germany 
        1. By Indication
      3.  France 
        1. By Indication
      4.  Spain 
        1. By Indication
      5.  Italy 
        1. By Indication
      6.  Scandinavia 
        1. By Indication
      7.  Rest of Europe 
        1. By Indication
  8. Asia Pacific Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1.  TNF Inhibitors
      2. Interleukins Inhibitors
        1. IL-17 Inhibitors
        2. IL-23/p19 Inhibitors
        3. IL-12/23 p40 Inhibitors
        4. Other Interleukins
      3. PDE4 Inhibitors
      4. TYK2 Inhibitors
      5. JAK Inhibitors
      6. Corticosteroids
      7. Vitamin D Analogs
      8. Retinoids
      9. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1.  Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Guttate Psoriasis
      4. Inverse Psoriasis
      5. Pustular Psoriasis
      6. Erythrodermic Psoriasis
      7. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1.  Biologics
      2.  Non-Biologics
    4.  Market Analysis, Insights and Forecast – By Route of Administration
      1.  Oral
      2.  Parenteral/Systemic
      3.  Topical
    5. Market Analysis, Insights and Forecast – By Age Group
      1.  Pediatric
      2.  Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1.  Hospital Pharmacies
      2. Retail Pharmacies
      3. Specialty Pharmacies
      4. Online Pharmacies
    7.  Market Analysis, Insights and Forecast – By Country/Sub-region
      1.  Japan 
        1. By Indication
      2.  China 
        1. By Indication
      3.  India 
        1. By Indication
      4.  Australia & New Zealand
        1. By Indication
      5.   Rest of Asia Pacific 
        1. By Indication
  9. Latin America Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1.  TNF Inhibitors
      2. Interleukins Inhibitors
        1. IL-17 Inhibitors
        2. IL-23/p19 Inhibitors
        3. IL-12/23 p40 Inhibitors
        4. Other Interleukins
      3. PDE4 Inhibitors
      4. TYK2 Inhibitors
      5. JAK Inhibitors
      6. Corticosteroids
      7. Vitamin D Analogs
      8. Retinoids
      9. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1.  Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Guttate Psoriasis
      4. Inverse Psoriasis
      5. Pustular Psoriasis
      6. Erythrodermic Psoriasis
      7. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1.  Biologics
      2.  Non-Biologics
    4.  Market Analysis, Insights and Forecast – By Route of Administration
      1.  Oral
      2.  Parenteral/Systemic
      3.  Topical
    5. Market Analysis, Insights and Forecast – By Age Group
      1.  Pediatric
      2.  Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1.  Hospital Pharmacies
      2. Retail Pharmacies
      3. Specialty Pharmacies
      4. Online Pharmacies
    7. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1.  Brazil 
        1. By Indication
      2.  Mexico 
        1. By Indication
      3.  Rest of Latin America 
        1. By Indication
  10. Middle East & Africa Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1.  TNF Inhibitors
      2. Interleukins Inhibitors
        1. IL-17 Inhibitors
        2. IL-23/p19 Inhibitors
        3. IL-12/23 p40 Inhibitors
        4. Other Interleukins
      3. PDE4 Inhibitors
      4. TYK2 Inhibitors
      5. JAK Inhibitors
      6. Corticosteroids
      7. Vitamin D Analogs
      8. Retinoids
      9. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1.  Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Guttate Psoriasis
      4. Inverse Psoriasis
      5. Pustular Psoriasis
      6. Erythrodermic Psoriasis
      7. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1.  Biologics
      2.  Non-Biologics
    4.  Market Analysis, Insights and Forecast – By Route of Administration
      1.  Oral
      2.  Parenteral/Systemic
      3.  Topical
    5. Market Analysis, Insights and Forecast – By Age Group
      1.  Pediatric
      2.  Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1.  Hospital Pharmacies
      2. Retail Pharmacies
      3. Specialty Pharmacies
      4. Online Pharmacies
    7. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1.  GCC 
        1. By Indication
      2.  South Africa 
        1. By Indication
      3.  Rest of Middle East & Africa 
        1. By Indication
  11. Competitive Analysis 
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1.  AbbVie Inc. 
      2.  Novartis AG 
      3.  Johnson & Johnson Services, Inc. 
      4.  Pfizer Inc. 
      5.  Eli Lilly and Company 
      6.  LEO Pharma A/S
      7.  Amgen Inc.
      8.  UCB S.A.
      9.  Sun Pharmaceutical Industries Ltd.
      10.  Almirall, S.A
      11.  Arcutis Biotherapeutics, Inc.
  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities 
    4. Market Trends
    5. Market Challenges
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Key Industry Developments, By Key Players
    3. Pipeline Analysis, By Key Players
    4. Overview: Regulatory Scenario & Reimbursement Scenario, By Key Countries/Region
    5. Prevalence of Psoriasis, By Key Countries, 2025
  5. Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1.  TNF Inhibitors
      2. Interleukins Inhibitors
        1. IL-17 Inhibitors
        2. IL-23/p19 Inhibitors
        3. IL-12/23 p40 Inhibitors
        4. Other Interleukins
      3. PDE4 Inhibitors
      4. TYK2 Inhibitors
      5. JAK Inhibitors
      6. Corticosteroids
      7. Vitamin D Analogs
      8. Retinoids
      9. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1.  Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Guttate Psoriasis
      4. Inverse Psoriasis
      5. Pustular Psoriasis
      6. Erythrodermic Psoriasis
      7. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1.  Biologics
      2.  Non-Biologics
    4.  Market Analysis, Insights and Forecast – By Route of Administration
      1.  Oral
      2.  Parenteral/Systemic
      3.  Topical
    5. Market Analysis, Insights and Forecast – By Age Group
      1.  Pediatric
      2.  Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1.  Hospital Pharmacies
      2. Retail Pharmacies
      3. Specialty Pharmacies
      4. Online Pharmacies
    7. Market Analysis, Insights and Forecast – By Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1.  TNF Inhibitors
      2. Interleukins Inhibitors
        1. IL-17 Inhibitors
        2. IL-23/p19 Inhibitors
        3. IL-12/23 p40 Inhibitors
        4. Other Interleukins
      3. PDE4 Inhibitors
      4. TYK2 Inhibitors
      5. JAK Inhibitors
      6. Corticosteroids
      7. Vitamin D Analogs
      8. Retinoids
      9. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1.  Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Guttate Psoriasis
      4. Inverse Psoriasis
      5. Pustular Psoriasis
      6. Erythrodermic Psoriasis
      7. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1.  Biologics
      2.  Non-Biologics
    4.  Market Analysis, Insights and Forecast – By Route of Administration
      1.  Oral
      2.  Parenteral/Systemic
      3.  Topical
    5. Market Analysis, Insights and Forecast – By Age Group
      1.  Pediatric
      2.  Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1.  Hospital Pharmacies
      2. Retail Pharmacies
      3. Specialty Pharmacies
      4. Online Pharmacies
    7. Market Analysis, Insights and Forecast  – By Country
      1.  U.S. 
        1.  By Indication
      2.  Canada 
        1.  By Indication
  7. Europe Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1.  TNF Inhibitors
      2. Interleukins Inhibitors
        1. IL-17 Inhibitors
        2. IL-23/p19 Inhibitors
        3. IL-12/23 p40 Inhibitors
        4. Other Interleukins
      3. PDE4 Inhibitors
      4. TYK2 Inhibitors
      5. JAK Inhibitors
      6. Corticosteroids
      7. Vitamin D Analogs
      8. Retinoids
      9. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1.  Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Guttate Psoriasis
      4. Inverse Psoriasis
      5. Pustular Psoriasis
      6. Erythrodermic Psoriasis
      7. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1.  Biologics
      2.  Non-Biologics
    4.  Market Analysis, Insights and Forecast – By Route of Administration
      1.  Oral
      2.  Parenteral/Systemic
      3.  Topical
    5. Market Analysis, Insights and Forecast – By Age Group
      1.  Pediatric
      2.  Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1.  Hospital Pharmacies
      2. Retail Pharmacies
      3. Specialty Pharmacies
      4. Online Pharmacies
    7. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1.  U.K 
        1. By Indication
      2.  Germany 
        1. By Indication
      3.  France 
        1. By Indication
      4.  Spain 
        1. By Indication
      5.  Italy 
        1. By Indication
      6.  Scandinavia 
        1. By Indication
      7.  Rest of Europe 
        1. By Indication
  8. Asia Pacific Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1.  TNF Inhibitors
      2. Interleukins Inhibitors
        1. IL-17 Inhibitors
        2. IL-23/p19 Inhibitors
        3. IL-12/23 p40 Inhibitors
        4. Other Interleukins
      3. PDE4 Inhibitors
      4. TYK2 Inhibitors
      5. JAK Inhibitors
      6. Corticosteroids
      7. Vitamin D Analogs
      8. Retinoids
      9. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1.  Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Guttate Psoriasis
      4. Inverse Psoriasis
      5. Pustular Psoriasis
      6. Erythrodermic Psoriasis
      7. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1.  Biologics
      2.  Non-Biologics
    4.  Market Analysis, Insights and Forecast – By Route of Administration
      1.  Oral
      2.  Parenteral/Systemic
      3.  Topical
    5. Market Analysis, Insights and Forecast – By Age Group
      1.  Pediatric
      2.  Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1.  Hospital Pharmacies
      2. Retail Pharmacies
      3. Specialty Pharmacies
      4. Online Pharmacies
    7.  Market Analysis, Insights and Forecast – By Country/Sub-region
      1.  Japan 
        1. By Indication
      2.  China 
        1. By Indication
      3.  India 
        1. By Indication
      4.  Australia & New Zealand
        1. By Indication
      5.   Rest of Asia Pacific 
        1. By Indication
  9. Latin America Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1.  TNF Inhibitors
      2. Interleukins Inhibitors
        1. IL-17 Inhibitors
        2. IL-23/p19 Inhibitors
        3. IL-12/23 p40 Inhibitors
        4. Other Interleukins
      3. PDE4 Inhibitors
      4. TYK2 Inhibitors
      5. JAK Inhibitors
      6. Corticosteroids
      7. Vitamin D Analogs
      8. Retinoids
      9. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1.  Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Guttate Psoriasis
      4. Inverse Psoriasis
      5. Pustular Psoriasis
      6. Erythrodermic Psoriasis
      7. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1.  Biologics
      2.  Non-Biologics
    4.  Market Analysis, Insights and Forecast – By Route of Administration
      1.  Oral
      2.  Parenteral/Systemic
      3.  Topical
    5. Market Analysis, Insights and Forecast – By Age Group
      1.  Pediatric
      2.  Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1.  Hospital Pharmacies
      2. Retail Pharmacies
      3. Specialty Pharmacies
      4. Online Pharmacies
    7. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1.  Brazil 
        1. By Indication
      2.  Mexico 
        1. By Indication
      3.  Rest of Latin America 
        1. By Indication
  10. Middle East & Africa Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1.  TNF Inhibitors
      2. Interleukins Inhibitors
        1. IL-17 Inhibitors
        2. IL-23/p19 Inhibitors
        3. IL-12/23 p40 Inhibitors
        4. Other Interleukins
      3. PDE4 Inhibitors
      4. TYK2 Inhibitors
      5. JAK Inhibitors
      6. Corticosteroids
      7. Vitamin D Analogs
      8. Retinoids
      9. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1.  Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Guttate Psoriasis
      4. Inverse Psoriasis
      5. Pustular Psoriasis
      6. Erythrodermic Psoriasis
      7. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1.  Biologics
      2.  Non-Biologics
    4.  Market Analysis, Insights and Forecast – By Route of Administration
      1.  Oral
      2.  Parenteral/Systemic
      3.  Topical
    5. Market Analysis, Insights and Forecast – By Age Group
      1.  Pediatric
      2.  Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1.  Hospital Pharmacies
      2. Retail Pharmacies
      3. Specialty Pharmacies
      4. Online Pharmacies
    7. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1.  GCC 
        1. By Indication
      2.  South Africa 
        1. By Indication
      3.  Rest of Middle East & Africa 
        1. By Indication
  11. Competitive Analysis 
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1.  AbbVie Inc. 
      2.  Novartis AG 
      3.  Johnson & Johnson Services, Inc. 
      4.  Pfizer Inc. 
      5.  Eli Lilly and Company 
      6.  LEO Pharma A/S
      7.  Amgen Inc.
      8.  UCB S.A.
      9.  Sun Pharmaceutical Industries Ltd.
      10.  Almirall, S.A
      11.  Arcutis Biotherapeutics, Inc.
Read Less

Figure 1: Global Psoriasis Treatment Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Psoriasis Treatment Market Value Share (%), by Indication, 2025 & 2034

Figure 3: Global Psoriasis Treatment Market Value Share (%), by Indication, 2025 & 2034

Figure 4: Global Psoriasis Treatment Market Value Share (%), by Product Type, 2025 & 2034

Figure 5: Global Psoriasis Treatment Market Value Share (%), by Route of Administration, 2025 & 2034

Figure 6: Global Psoriasis Treatment Market Value Share (%), by Age Group, 2025 & 2034

Figure 7: Global Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 8: Global Psoriasis Treatment Market Value Share (%), by Region, 2025 & 2034

Figure 9: North America Psoriasis Treatment Market Value (USD billion), by Indication, 2025 & 2034

Figure 10: North America Psoriasis Treatment Market Value Share (%), by Indication, 2025

Figure 11: North America Psoriasis Treatment Market Value (USD billion), by Indication, 2025 & 2034

Figure 12: North America Psoriasis Treatment Market Value Share (%), by Indication, 2025

Figure 13: North America Psoriasis Treatment Market Value (USD billion), by Product Type 2025 & 2034

Figure 14: North America Psoriasis Treatment Market Value Share (%), by Product Type 2025

Figure 15: North America Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 16: North America Psoriasis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 17: North America Psoriasis Treatment Market Value (USD billion), by Age Group, 2025 & 2034

Figure 18: North America Psoriasis Treatment Market Value Share (%), by Age Group, 2025

Figure 19: North America Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 20: North America Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 21: North America Psoriasis Treatment Market Value (USD billion), by Country, 2025 & 2034

Figure 22: North America Psoriasis Treatment Market Value Share (%), by Country, 2025

Figure 23: Europe Psoriasis Treatment Market Value (USD billion), by Indication, 2025 & 2034

Figure 24: Europe Psoriasis Treatment Market Value Share (%), by Indication, 2025

Figure 25: Europe Psoriasis Treatment Market Value (USD billion), by Indication, 2025 & 2034

Figure 26: Europe Psoriasis Treatment Market Value Share (%), by Indication, 2025

Figure 27: Europe Psoriasis Treatment Market Value (USD billion), by Product Type 2025 & 2034

Figure 28: Europe Psoriasis Treatment Market Value Share (%), by Product Type 2025

Figure 29: Europe Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 30: Europe Psoriasis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 31: Europe Psoriasis Treatment Market Value (USD billion), by Age Group, 2025 & 2034

Figure 32: Europe Psoriasis Treatment Market Value Share (%), by Age Group, 2025

Figure 33: Europe Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 34: Europe Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 35: Europe Psoriasis Treatment Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 36: Europe Psoriasis Treatment Market Value Share (%), by Country/ Sub-region, 2025

Figure 37: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Indication, 2025 & 2034

Figure 38: Asia Pacific Psoriasis Treatment Market Value Share (%), by Indication, 2025

Figure 39: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Indication, 2025 & 2034

Figure 40: Asia Pacific Psoriasis Treatment Market Value Share (%), by Indication, 2025

Figure 41: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Product Type 2025 & 2034

Figure 42: Asia Pacific Psoriasis Treatment Market Value Share (%), by Product Type 2025

Figure 43:  Asia Pacific Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 44: Asia Pacific Psoriasis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 45: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Age Group, 2025 & 2034

Figure 46: Asia Pacific Psoriasis Treatment Market Value Share (%), by Age Group, 2025

Figure 47: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 48:  Asia Pacific Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 49: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 50: Asia Pacific Psoriasis Treatment Market Value Share (%), by Country/ Sub-region, 2025

Figure 51: Latin America Psoriasis Treatment Market Value (USD billion), by Indication, 2025 & 2034

Figure 52: Latin America Psoriasis Treatment Market Value Share (%), by Indication, 2025

Figure 53: Latin America Psoriasis Treatment Market Value (USD billion), by Indication, 2025 & 2034

Figure 54: Latin America Psoriasis Treatment Market Value Share (%), by Indication, 2025

Figure 55: Latin America Psoriasis Treatment Market Value (USD billion), by Product Type 2025 & 2034

Figure 56: Latin America Psoriasis Treatment Market Value Share (%), by Product Type 2025

Figure 57: Latin America Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 58: Latin America Psoriasis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 59: Latin America Psoriasis Treatment Market Value (USD billion), by Age Group, 2025 & 2034

Figure 60: Latin America Psoriasis Treatment Market Value Share (%), by Age Group, 2025

Figure 61: Latin America Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 62: Latin America Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 63: Latin America Psoriasis Treatment Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 64: Latin America Psoriasis Treatment Market Value Share (%), by Country/ Sub-region, 2025

Figure 65: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Indication, 2025 & 2034

Figure 66: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Indication, 2025

Figure 67: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Indication, 2025 & 2034

Figure 68: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Indication, 2025

Figure 69: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Product Type 2025 & 2034

Figure 70: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Product Type 2025

Figure 71: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 72: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 73: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Age Group, 2025 & 2034

Figure 74: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Age Group, 2025

Figure 75: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 76: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 77: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 78: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Country/ Sub-region, 2025

Figure 79: Global Psoriasis Treatment Market Share (%), by Company, 2025

Table 1: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021–2034

Table 2: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Interleukins, 2021–2034

Table 3: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 4: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type 2021–2034

Table 5: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 6: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Age Group, 2021–2034

Table 7: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 8: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 9: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021–2034

Table 10:  North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Interleukins, 2021–2034

Table 11: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 12: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type 2021–2034

Table 13: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 14: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Age Group, 2021–2034

Table 15: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 16: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Country, 2021-2034

Table 17: U.S. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 18: Canada Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 19: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021–2034

Table 20: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Interleukins, 2021–2034

Table 21: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 22: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type 2021–2034

Table 23: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 24: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Age Group, 2021–2034

Table 25: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 26: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

Table 27: U.K. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 28: Germany Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 29: Canada Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 30: France Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 31: Spain Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 32: Italy Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 33: Scandinavia Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 34: Rest of Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 35: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021–2034

Table 36: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Interleukins, 2021–2034

Table 37: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 38: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type 2021–2034

Table 39: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 40: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Age Group, 2021–2034

Table 41: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 42: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

Table 43: Japan Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 44: China Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 45: India Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 46: Australia & New Zealand Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 47: Rest of Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 48: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021–2034

Table 49: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Interleukins, 2021–2034

Table 50: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 51: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type 2021–2034

Table 52: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 53: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Age Group, 2021–2034

Table 54: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 55: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

Table 56: Brazil Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 57: Mexico Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 58: Rest of Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 59: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021–2034

Table 60: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Interleukins, 2021–2034

Table 61: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 62: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type 2021–2034

Table 63: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 64: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Age Group, 2021–2034

Table 65: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 66: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

Table 67: GCC Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 68: South Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 69: Rest of Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Psoriasis Treatment Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 190
Download Free Sample

    man icon
    Mail icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Customize Now
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports